Inventor · disambiguated record
Daniel Afar
Also filed as: AFAR DANIEL · AFAR DANIEL E · AFAR DANIEL E H
94 granted patents·46 pending applications·1,161 citations·filing 1999–2023
99Inventor score
Files withAGENSYS INC80ABBVIE BIOTHERAPEUTICS INC9AFAR DANIEL E5FACET BIOTECH CORP5EOS BIOTECHNOLOGY INC3
Top patents by PatentIndex Score
140 records- 0199US7485299B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Feb 3, 2009·49 cites·18 claims
- 0298US7507541B236P6D5: secreted tumor antigenAGENSYS INC·Filed 2007·Granted Mar 24, 2009·89 cites·26 claims
- 0398US6329503B1Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 1999·Granted Dec 11, 2001·147 cites·16 claims
- 0497US7641905B2Methods of inducing an immune responseAGENSYS INC·Filed 2005·Granted Jan 5, 2010·25 cites·4 claims
- 0597US7628989B2Methods of inducing an immune responseAGENSYS INC·Filed 2005·Granted Dec 8, 2009·23 cites·4 claims
- 0696US9914783B1Anti-PD-1 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2017·Granted Mar 13, 2018·61 cites·17 claims
- 0796US7053186B2Antibodies immunospecific for STEAP1AGENSYS INC·Filed 2001·Granted May 30, 2006·48 cites·7 claims
- 0895US8414898B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAFAR DANIEL E·Filed 2011·Granted Apr 9, 2013·35 cites·24 claims
- 0994US7928201B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Apr 19, 2011·16 cites·20 claims
- 1094US7642054B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2005·Granted Jan 5, 2010·19 cites·21 claims
- 1194US7611904B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Nov 3, 2009·19 cites·39 claims
- 1294US7166714B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2003·Granted Jan 23, 2007·35 cites·6 claims
- 1394US6887975B2Peptides derived from STEAP1AGENSYS INC·Filed 2001·Granted May 3, 2005·40 cites·8 claims
- 1493US7968307B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Jun 28, 2011·14 cites·22 claims
- 1592US6943235B1Transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2000·Granted Sep 13, 2005·34 cites·10 claims
- 1691US8603477B2Use of anti-CS1 antibodies for treatment of rare lymphomasAFAR DANIEL·Filed 2009·Granted Dec 10, 2013·59 cites·30 claims
- 1791US7674883B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Mar 9, 2010·6 cites·14 claims
- 1891US7288248B2Antibodies against cancer antigen TMEFF2 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 30, 2007·27 cites·7 claims
- 1991US7037667B1Tumor antigen useful in diagnosis and therapy of prostate and colon cancerAGENSYS INC·Filed 2000·Granted May 2, 2006·41 cites·10 claims
- 2091US6893818B1Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2000·Granted May 17, 2005·19 cites·1 claims
- 2189US7575749B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted Aug 18, 2009·18 cites·3 claims
- 2289US7223542B236P6D5: secreted tumor antigenAGENSYS INC·Filed 2003·Granted May 29, 2007·13 cites·2 claims
- 2388US6833438B1Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 1999·Granted Dec 21, 2004·45 cites·6 claims
- 2488US6566078B136P6D5: secreted tumor antigenAGENSYS INC·Filed 2000·Granted May 20, 2003·12 cites·10 claims
- 2587US7842293B2Compositions and methods using anti-CS1 antibodies to treat multiple myelomaFACET BIOTECH CORP·Filed 2007·Granted Nov 30, 2010·7 cites·7 claims
- 2686US8053551B2Serpentine transmembrane antigens expressed in human cancers and uses thereforAGENSYS INC·Filed 2003·Granted Nov 8, 2011·7 cites·2 claims
- 2786US7771968B2Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2008·Granted Aug 10, 2010·2 cites·9 claims
- 2886US7510840B1Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibodyAGENSYS INC·Filed 2002·Granted Mar 31, 2009·16 cites·7 claims
- 2986US7459539B2Antibody that binds zinc transporter protein 108P5H8AGENSYS INC·Filed 2001·Granted Dec 2, 2008·16 cites·12 claims
- 3086US7455991B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted Nov 25, 2008·14 cites·6 claims
- 3185US7947459B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted May 24, 2011·19 cites·11 claims
- 3285US7795391B2Protein showing enhanced expression in cancer cellsAGENSYS INC·Filed 2007·Granted Sep 14, 2010·8 cites·6 claims
- 3385US6602501B1C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereofAGENSYS INC·Filed 2000·Granted Aug 5, 2003·13 cites·13 claims
- 3484US7824678B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Nov 2, 2010·4 cites·9 claims
- 3583US8241626B2Serpentine transmembrane antigens expressed in human cancers and uses thereofHUBERT RENE S·Filed 2006·Granted Aug 14, 2012·7 cites·11 claims
- 3683US7217799B2Antibodies that recognize the 85P1B3 protein useful in treatment and detection of cancerAGENSYS INC·Filed 2001·Granted May 15, 2007·5 cites·8 claims
- 3783US6924358B2121P1F1: a tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2001·Granted Aug 2, 2005·5 cites·4 claims
- 3881US7785816B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Aug 31, 2010·2 cites·4 claims
- 3978US7501502B2Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancerAGENSYS INC·Filed 2006·Granted Mar 10, 2009·1 cites·11 claims
- 4077US7319006B2Serpentine transmembrane antigens expressed in human cancers and uses thereofGENENTECH INC·Filed 2004·Granted Jan 15, 2008·20 cites·13 claims
- 4176US8383777B213-transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2007·Granted Feb 26, 2013·2 cites·8 claims
- 4275US7488479B2Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancerAGENSYS INC·Filed 2002·Granted Feb 10, 2009·1 cites·3 claims
- 4375US7306796B213-transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2002·Granted Dec 11, 2007·7 cites·8 claims
- 4475US6863892B2Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancersAGENSYS INC·Filed 2001·Granted Mar 8, 2005·5 cites·9 claims
- 4575US6277972B1BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cellsUROGENESYS INC·Filed 1999·Granted Aug 21, 2001·30 cites·10 claims
- 4674US7892548B2121P1F1: a tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2007·Granted Feb 22, 2011·0 cites·10 claims
- 4774US7736654B2Nucleic acids and corresponding proteins useful in the detection and treatment of various cancersAGENSYS INC·Filed 2002·Granted Jun 15, 2010·1 cites·1 claims
- 4874US7271240B2125P5C8: a tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2001·Granted Sep 18, 2007·2 cites·3 claims
- 4973US7928212B2Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2010·Granted Apr 19, 2011·1 cites·17 claims
- 5072US8022174B2C-type lectin transmembrane antigen expressed in human prostate cancer and uses therofAGENSYS INC·Filed 2009·Granted Sep 20, 2011·0 cites·5 claims
Showing the top 50 of 140 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel Afar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →